Safety and Efficacy of Privigen®, a Novel 10% Liquid Immunoglobulin Preparation for Intravenous Use, in Patients with Primary Immunodeficiencies

200894 citationsJournal Articlehybrid Open Access

Authors

Privigen is well tolerated and effective for the treatment of primary immunodeficiency.

Good health and well-being

Published in: Journal of Clinical Immunology

Volume 29, Issue 1, pp. 137-144

Field-Weighted Citation Impact: 3.10